Bigfinite, a biotech and pharma software provider, completed $8.5 million in seed financing, led by Crosslink Capital, Uncork Capital, and La Famiglia. Industry Ventures and Krohne also participated in the funding.
The company’s SaaS platform acquires, visualizes, and records regulated data from biotech and pharma manufacturing sites, and then analyzes that data in real time to detect inefficiencies throughout the supply chain, from research and development to patient dispensing.
Bigfinite plans to use this seed round of capital to expand its business development and customer support efforts.